Scientists Launch Legal Challenge to DEA's Proposed Psychedelic Scheduling, Which Would Criminalize Research Compounds and Jeopardize FDA Breakthrough Therapy for Postpartum Depression
Early career scientists from Students for Sensible Drug Policy (SSDP) — the largest youth-led grassroots network dedicated to ending the War on Drugs — join forces with a psychedelic drug developer in challenging the DEA's proposed Schedule I placement of five tryptamines, warning of serious consequences for scientific research and promising medical treatments.
